A C. elegans model for neurodegeneration in Cockayne syndrome. by Lopes, Amanda FC et al.
Published online 6 October 2020 Nucleic Acids Research, 2020, Vol. 48, No. 19 10973–10985
doi: 10.1093/nar/gkaa795
A C. elegans model for neurodegeneration in
Cockayne syndrome
Amanda F.C. Lopes1,2, Katarzyna Bozek3, Marija Herholz2,4, Aleksandra Trifunovic 2,3,4,
Matthias Rieckher1,2,* and Björn Schumacher 1,2,3,*
1Institute for Genome Stability in Aging and Disease, Medical Faculty, University of Cologne, Joseph-Stelzmann-Str.
26, 50931 Cologne, Germany, 2Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated
Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany, 3Center for
Molecular Medicine (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne,
Robert-Koch-Str. 21, 50931 Cologne, Germany and 4Institute for Mitochondrial Diseases and Aging, Medical Faculty,
University of Cologne, D-50931 Cologne, Germany
Received June 22, 2020; Revised September 08, 2020; Editorial Decision September 10, 2020; Accepted September 27, 2020
ABSTRACT
Cockayne syndrome (CS) is a congenital syndrome
characterized by growth and mental retardation, and
premature ageing. The complexity of CS and mam-
malian models warrants simpler metazoan models
that display CS-like phenotypes that could be stud-
ied in the context of a live organism. Here, we pro-
vide a characterization of neuronal and mitochon-
drial aberrations caused by a mutation in the csb-
1 gene in Caenorhabditis elegans. We report a pro-
gressive neurodegeneration in adult animals that is
enhanced upon UV-induced DNA damage. The csb-1
mutants show dysfunctional hyperfused mitochon-
dria that degrade upon DNA damage, resulting in di-
minished respiratory activity. Our data support the
role of endogenous DNA damage as a driving factor
of CS-related neuropathology and underline the role
of mitochondrial dysfunction in the disease.
INTRODUCTION
Cockayne syndrome (CS) is an autosomal recessive ge-
netic disorder with an occurrence of 2.5 cases per million
births worldwide, and it is caused by mutations in the two
genes ERCC8, also known as CSA, and ERCC6, com-
monly described as CSB, accounting for 20% and 80% of
CS cases, respectively (1–3). The CSA and CSB proteins ini-
tiate transcription-coupled nucleotide excision repair (TC-
NER) upon RNA polymerase II stalling to remove helix-
distorting lesions such as UV-induced cyclobutane pyrim-
idine dimers (CPDs) (4). The spectrum of clinical features
observed in CS patients ranges from cutaneous photosensi-
tivity, retarded development, loss of subcutaneous fat, hear-
ing and vision loss, cachectic dwarfism, stooped posture,
and progressive neurodegeneration (1,3,4). Many traits of
CS patients are reminiscent of age-related pathologies, clas-
sifying it as a progeroid syndrome (2).
Although the role of CSA and CSB in NER has been
intensely investigated, the pleiotropic phenotypes associ-
ated with their dysfunction and the cellular and molecu-
lar defects underlying the symptoms are still poorly under-
stood. A limited number of patients, most of which are com-
pound heterozygotes, and the complexity and diversity of
the symptoms challenge the study of the disease. It is un-
clear whether a single cellular process or whether a com-
bination of events caused by various mechanisms could be
contributing to the pathology differentially, synergistically
and in cell type-specific ways (5). Thus, deciphering CS on a
molecular level will provide further understanding of its un-
derlying pathologies and the mechanisms of normal ageing,
ultimately allowing for the design of possible intervention
strategies.
Current systems for studying CS include mouse models
of CSA, which recapitulate the human clinical features of
UV-sensitivity (4); and the mouse model for CSB, which
presents loss of spiral gangliocytes in the inner ear and
cachectic dwarfism, apart from UV-sensitivity (6). Csa- and
Csb-deficient mice, nevertheless, show pronounced suscep-
tibility to skin cancer, which is not found in human cases
of CS, and fail to exhibit any gross anatomical abnormal-
ities (1,2,4,7). Neurodegenerative features commonly seen
in CS patients only become apparent in mouse models with
CS when these are crossed with mice with other deficiencies
in the NER, such as Xpc−/− or Xpa−/− (1,8). While these
mouse studies have been important for understanding some
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of the clinical features observed in humans, the diversity of
the phenotypes observed in mammals, particularly in CS,
renders the need for establishing a simple whole-organism
model system. Therefore, we evaluated the CS-like model
character of Caenorhabditis elegans, an organism that, al-
though rudimentarily organized, contains many of the dis-
tinct cell types conducting distinct functions, as is seen in
mammals, such as muscle cells, neurons, and intestinal cells
(9).
Caenorhabditis elegans has become widely used as a sim-
ple model organism to untangle complex mechanisms un-
derlying the DNA damage response and human diseases,
particularly in the context of ageing (10). The proteins CSA
and CSB are well conserved throughout evolution, and mu-
tations in the respective genes have also been described in C.
elegans (11,12). Nematodes that carry mutations in csa-1 or
csb-1, display developmental growth retardation and lifes-
pan shortening upon UV treatment (11,13–15). Given the
phenotypic parallels between the UV-induced phenotypes
in the nematode and the progeroid pathologies in CS pa-
tients, we sought to establish whether the C. elegans model
might recapitulate neurodegenerative phenotypes. Indeed,
with only 302 neurons, a fully mapped connectome and
availability of advanced neuroimaging methods, the nema-
tode has proven exemplary in pursuing the mechanistic link
between neural circuits and behaviour, such as locomotion
(16), chemotaxis (17) and mechanosensation (18), as well
as the intricate mechanisms of neurodegeneration in ageing
and disease (19).
Here, we demonstrate that csb-1 mutants exhibit progres-
sive functional loss of sensory neuronal function that is ex-
acerbated by UV irradiation or infliction of transcription-
blocking DNA lesions by the fungal toxin Illudin M, em-
phasizing the causal role of DNA lesions in the pathology.
We determine different types of progressive neuronal de-
fects, with an accentuated level of beading (described as
focal enlargements along the axonal process) in csb-1 mu-
tant animals, a phenotype, which precedes neuronal degen-
eration (20). Consistent with a role of mitochondrial dys-
function in CS-related functional deterioration, we observe
higher levels of mitochondrial mass and a disturbed mito-
chondrial network. Despite those alterations, csb-1 mutants
maintain respiratory activity, while exogenous DNA dam-
age triggers fragmentation of the mitochondrial networks
and loss of respiratory activity. In summary, we propose the
C. elegans csb-1 mutant as a model to study mechanisms of
CS, in particular, neuronal abnormalities.
MATERIALS AND METHODS
C. elegans strains and maintenance
Caenorhabditis elegans were grown at 20◦C on NGM
plates with E. coli strain OP50 (21) and grown in light
protected incubators to minimize DNA lesions re-
sulting from visible light (22). Strains used were (see
Supplementary Table S1): N2 (Bristol, Wild type);
RB1801, csb-1(ok2335) X.; CB4037, glp-1(e2141) III.,
BJS259, glp-1(e2141);csb-1(ok2335); to image and
measure mitochondrial mass we used SJ4103, zcls14[myo-
3::GFP(mit)] and SJ4143, zcls17[ges-1::GFP(mit)], and
created BJS348, zcls14[myo-3::GFP(mit)];csb-1(ok2335),
BJS332, zcls17[ges-1::GFP(mit)];csb-1(ok2335) double-
mutants. To image neurodegeneration we used CZ10175,
zdls5[mec-4::GFP+lin-15(+)] I, and created BJS333,
zdls5[mec-4::GFP+lin-15(+)]I;csb-1(ok2335). The CSB-
1::GFP rescue line was created via co-microinjection (23) of
Fosmid CBGtg9050A06211D of the TransgeneOme project
(24) and a pharyngeal tdTomato co-injection marker
(pmyo-2tdTomato into csb-1(ok2335), followed by gamma
radiation-induced integration of the extrachromosmal ar-
ray. The resulting strain BJS960, sbjIs59[pBS28(pcsb-1CSB-
1::GFP)+pBS174(myo-2::tdTomato)] was backcrossed
with the csb-1(ok2335) mutant three times.
Locomotion assay
Animals were synchronized via sodium hypochlorite treat-
ment and grown into Day 1 of adulthood. About 200
worms per strain and condition were transferred to fresh
OP50-seeded and mock-treated, or treated with UVB
(80 mJ/cm2), respectively. Videos (∼1.5 min) of worm lo-
comotion were captured 24 h post-UVB irradiation with a
Zeiss Axio Zoom V.16 microscope equipped with an Ax-
iocam 503 mono. To quantify posture and mobility as-
pects of the animals we used TierpsyTracker (25). Us-
ing the software interface we adapted segmentation pa-
rameters (range of size of foreground patches, foreground-
background threshold), keeping all remaining parameters
at their default values. We batch-processed all video files
obtaining trajectory information of the segmented worms
excluding overlapping events and young individuals. We ad-
ditionally removed all trajectories shorter than 5 s from fur-
ther analysis. We obtained 50–123 worm trajectories per
condition, with median trajectory length of 24 s. We next ex-
tracted posture and motility features of the tracked worms
quantified by the TierpsyTracker software, such as speed,
angular velocity, path range, etc. and compared their dis-
tribution between wild type, csb-1 mutant and the CSB-
1::GFP rescue line.
Chemotaxis assay
About 200 Day 1-adult worms per strain and condition
were treated with UVB (100 mJ/cm2), or mock-treated, re-
spectively. The next Day (24 h post-UVB irradiation) the
animals were washed three times with M9 to remove resid-
ual bacteria. Chemotaxis assay plates were freshly prepared
15 min prior to the experiment as previously described (26).
Briefly, the chemoattractant 1 l of benzaldehyde (Sigma-
Aldrich, 1:200 dilution in Ethanol) was spotted on empty
60 mm NGM agar plates in equidistant angles, ∼2.5 cm
from the center (neutral zone), as indicated in Figure 1C.
Ethanol served as control. For OP50 Escherichia coli bacte-
ria attraction, a saturated over-night culture was prepared
and 10× concentrated. 1 l of OP50 was spotted on NGM
agar plates, while LB medium served as control. To each
spot 1 l of 1 M NaN3 (sodium azide, Sigma-Aldrich) was
added. C. elegans were concentrated in a volume of 20 l
and placed in the center of the assay plates. Worm distribu-
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Figure 1. Behavioural changes imply neuronal defects in csb-1 mutants. (A) Pharyngeal pumping in wt and csb-1 mutants upon UVB irradiation. Ne-
matodes were irradiated at Day 1 of adulthood, and assayed 24 h after irradiation (Day 2), 48 h later (Day 3) and 72 h later (Day 4) (n > 15 per group).
(B) Pharyngeal pumping measured in the wt, the csb-1 mutant and the csb-1(ok2335);CSB-1::GFP rescue line upon UVB irradiation. Nematodes were
irradiated at Day 1 of adulthood, and assayed 48 h after irradiation (n > 13 per group). (C) Pharyngeal pumping in the wt and csb-1(ok2335) (each
carrying the pmec-4GFP neuronal reporter) and the csb-1(ok2335);CSB-1::GFP rescue line upon Illudin M treatment at different concentrations. Whiskers
in (A) to (C) show the SD, statistics were computed with the non-parametric Mann-Whitney test with *P < 0.05, **P < 0.01, ***P < 0.001 and ****P <
0.0001 and Tukey outliers. (D, F) display locomotion features of wt, the csb-1 mutant and the csb-1(ok2335);pcsb-1CSB-1::GFP rescue line 24 h after UVB
irradiation, with (D) mean speed, (E) mean path curvature, and (F) mean path range (in A.U.) (n ≥ 60). Significance is measured via the Mann-Whitney
test with *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001, and Tukey outliers are shown as dots. Statistical significance in (A) to (F) without
specific indication always refers to the colour-matched untreated control. (G) Experiment scheme of the chemotaxis assay (see Materials and Methods).
(H) and (I) are chemotaxis assays in the wt, the csb-1 mutant and the csb-1(ok2335);pcsb-1CSB-1::GFP rescue line, quantified after 30 and 90 min, while
(H) uses benzaldehyde, and (I) OP50 E. coli as attractant, respectively. Significance between zone-specific localization compared to the wt is measured by
using the Welch’s t-test with *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.
Pharyngeal pumping assay
Caenorhabditis elegans at Day 1 of adulthood were irra-
diated with different UVB doses (as indicated), and their
pharyngeal pumping rates were accessed as the number of
pumps in 30 s, on the day of irradiation, and during the two
following days. Measurements were taken at a Zeiss Axio
Zoom V.16.
Oxygen consumption assay
Oxygen consumption was assessed using the Agilent Sea-
horse XFe96 Analyzer machine and the software Seahorse
Wave adopted from (27). Worms were irradiated with UVB
radiation at different doses during the early L4 larval stage,
and were placed for measurements in 96-well plates in
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The calibration plate was prepared the night before the ex-
periment, and kept at 37◦C overnight, as described by the
manufacturer. On the Day of the assay, the calibration plate
was allowed to reach room temperature before being used
to calibrate the machine. After calibration, the plate with
worms was added and the basal oxygen consumption rate
(OCR) was measured 10 times.
Neuronal defect scoring
Using a confocal Zeiss AxioImager M1 microscope at
40× magnification, the neuronal defect classifications were
observed and scored. Fifty worms carrying the zdls5[mec-
4::GFP+lin-15(+)] I. reporter transgene that were UVB
treated at Day 1 of adulthood were placed on a slide with
2% agar pad, in 20 l levamisole (Sigma Aldrich, 5 mM
in water). Axonal beading severity was quantified in the
same way. Different categories of severity of beading are
presented according to the number of beads counted per
animal. Time-lapse images of axonal beading progressing
into degeneration were taken on Day 8 after UVB treatment
of adult worms, using a similar method and microscope as
described above, however with 5% agar pads and 20 l of
nanobeads (Polysciences, Inc., 2.5% by volume, 0.1 m di-
ameter) to ensure the animal did not dry out.
Gentle touch sensitivity assay
Worms were synchronized via sodium hypochlorite treat-
ment and grown into Day 1 of adulthood, to be UVB-
treated. For the measurements at the indicated time-points,
the animals were stroked gently across their body with an
eyelash hair, at the head and behind the pharynx to stimu-
late the ALM neurons, and close to the tail and the anus to
stimulate the PLM neurons. The following were classified
as a sensitivity to the stimulus: if the animal was still but
moved after touch, if the animal was moving but stopped
after touch, and if the animal was moving and changed di-
rections after touch (28).
Neuronal degeneration scoring
Neuronal degeneration was scored using the zdls5[mec-
4::GFP+lin-15(+)]I reporter line and a Zeiss AxioImager
M1 microscope at 63× magnification. Thirty worms that
were UVB treated at early L4 stage were placed on a slide
with 2% agar pad in 20 l of levamisole (Sigma Aldrich,
5 mM in water) for immobilization. Beading axons were lo-
calized and closely investigated for the absence of axons be-
tween the beads, indicating neuronal breakage. For time-
lapses the animals were immobilized in 20 l of nanobeads
(Polysciences, Inc., 2.5% by volume, 0.1 m diameter) as
described previously (29).
Illudin M treatment
Illudin M (Cayman Chemical) was dissolved in dimethyl-
sulfoxide (DMSO) to a stock concentration of 0.25 mg/ml.
For the treatment, worms were synchronized via hypochlo-
ride treatment and grown into the L4 stage on OP50-seeded
NGM plates. The animals were washed three times with M9
and then treated for 16 h in 2 ml K-medium (2.36 g KCl, 3
g NaCl in 1 l ddH2O, autoclaved) containing cholesterol (5
g/ml), heat-inactivated OP50, and Illudin M in the indi-
cated concentrations. We added 0.075% DMSO to the con-
trol, which corresponds to the 30 g/ml Illudin M treat-
ment. After the treatment, the samples were washed three
times with M9 and the worms were seeded to OP50-seeded
NGM plates. Upon a recovery phase of 2 h, pharyngeal
pumping rates were determined. 24 h after, the neuronal
network was closely examined for neuronal defects, as de-
scribed above.
Mitochondrial mass assays
For the measurements of mitochondrial mass, the ani-
mals with the reporter lines zcls14[myo-3::GFP(mit)] and
zcls17[ges-1::GFP(mit)] were grown synchronized until
the early L4 larval stage and treated with UVB. At the dif-
ferent time points assayed, the animals were washed off the
plates with M9 medium, washed once with M9 and pelleted
at 1300 rpm for 1 min. The supernatant was removed to
approx. 20 l and 2 l of 50 mM levamisole were added
before mounting the animals on 2% agarose pads for imag-
ing at a Zeiss AxioImager M1 microscope with a 5× lens.
For the large particle flow measurements the animals were
transferred to 50 ml falcons to be quantified in the Biosorter
(Union Biometrica BioSorter with FlowPilot Sotware).
TMRE assay
For the TMRE staining experiments, C. elegans were grown
until the early L4 larval stage and UVB-treated. TMRE
staining at the indicated time points was done on NGM
agar plates at a concentration of 30 M dissolved with heat
inactivated OP50 (30 min, 65◦C). Once the plates were dry,
animals were added via picking and left to take up the dye
for 2 h. After staining, the animals were washed with M9
and moved to NGM plates spread with heat inactivated
OP50 to avoid active bacteria from taking up the dye and
staining the intestines of the worm. After 1 h crawling on
the plates without the dye, the animals were washed and pre-
pared for imaging as described in the mitochondrial mass
assay. For large particle flow quantification the worms were
washed into 50 ml falcons and fluorescence intensity levels
were measured via the biosorter.
Mitochondrial network analysis
Using the zcls14[myo-3::GFP(mit)] reporter line, the mi-
tochondrial network was examined by observing the muscle
cell number 18. Synchronized early L4 animals were treated
with UVB radiation, and at the different time points, 30
animals per condition were scored using a confocal Zeiss
AxioImager M1 microscope at ×63 magnification. Worms
were mounted onto slides with 2% agar, and immobilized in
20 l of nanobeads (Polysciences, Inc., 2.5% by volume, 0.1
m diameter).
Statistical analysis
Statistical analyses and graphing were carried out using
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Diego, USA) and the statistical computing language R
(http://www.R-project.org). The statistical tests applied for
each experiment are presented in the figure legends.
RESULTS
Somatic tissue functionality is reduced in csb-1 mutant ani-
mals
CS patients show a number of behavioural, cognitive and
perceptual abnormalities, including ocular abnormalities,
sensorineural hearing loss and disturbed gait (4). We used
csb-1 deficient C. elegans to assess possible behavioural de-
fects with or without UV treatment of post-mitotic, somatic
tissues in adult animals. Pharyngeal pumping rates are a
sensitive parameter of the functionality of a somatic tis-
sue and decline rapidly in completely NER-deficient xpa-
1 mutant animals following UVB treatment (10,15). csb-1
mutant animals show decreased pharyngeal pumping rates
compared to wildtype (wt) animals at Day 2 of adulthood,
which was accentuated with UV irradiation and progressed
over the first 4 days of adulthood (Figure 1A). To ensure
that this result was in fact due to the loss of CSB-1, we
generated a genetic rescue transgenic strain that ectopi-
cally expresses the wt CSB-1 protein under the control of
the csb-1 promoter in the csb-1 mutant background (csb-
1(ok2335);pcsb-1CSB-1::GFP). This genetic rescue strain
showed a significant alleviation of the pumping defect. The
UV sensitivity of csb-1 mutants was completely restored in
the rescue line (Figure 1B). To further validate whether the
declining tissue functionality was caused by transcription-
blocking lesions, we next assessed pharyngeal pumping in
the animals treated with Illudin M. This sesquiterpene from
the fungus O. illudens inflicts transcription-blocking DNA
lesions and is highly cytotoxic to TC-NER deficient human
cells and, when applied during early development, compro-
mises larval growth in TC-NER deficient worms (13,30,31).
Illudin M treatment of csb-1 mutant animals resulted in
a dose-dependent decline in pharyngeal pumping that was
significantly rescued by transgenic expression of wt CSB-
1::GFP (Figure 1C).
We extended our analysis to locomotion functions and
found that the mean speed of adult csb-1 mutants was sig-
nificantly reduced (Figure 1D). At the same time, the si-
nusoidal path curvature that is characteristic for C. elegans
movement was abnormally enhanced, resulting in a short-
ened mean path range (Figure 1E, F). Locomotion dysfunc-
tion was significantly increased upon exposure to UV, which
was partially suppressed in the CSB-1::GFP rescue line
(Figure 1D–F). Similarly, Illudin M treatment caused a re-
duction in mean speed that was strongly exacerbated in csb-
1 mutants and in turn significantly alleviated by the trans-
genic expression of the CSB-1::GFP (Supplementary Fig-
ure S1). To further address the neuronal functionality, we
assessed attraction behaviour to volatile chemicals, which
is mediated by a subset of chemosensory neurons in C. ele-
gans (32). We used a chemotaxis assay to test the attraction
of csb-1 mutants to benzaldehyde, or OP50 E. coli bacte-
ria, respectively (Figure 1G) (26). While most wt animals
localised to the chemoattractants within 30 min, csb-1 mu-
tants resided in the neutral areas of the plate for extended
time periods, indicating a loss of chemosensory function,
a phenotype that persisted after 90 min. Chemoattraction
was restored in the CSB-1::GFP rescue line. Pre-treatment
with UV robustly aggravated loss of chemosensation specif-
ically in csb-1 mutants (Figure 1H, I). Together, these results
show that CSB-1 deficient C. elegans display behavioural al-
terations, which are indicative of neuronal dysfunctions.
csb-1 mutants have gentle touch mechanosensory neuronal
defects
CS patients show progressive neurological dysfunction,
with abnormal myelin, brain atrophy and microcephaly
being key features (1). To investigate whether C. elegans
deficient for CSB-1 show signs of neurodegeneration, we
examined the gentle touch response that is mediated by
the mechanosensory neurons, posterior lateral microtubule
cells (PLM), anterior lateral microtubule cells (ALM), and
posterior ventral microtubule cell (PVM) (18). The integrity
of those neurons can be followed in live worms by using
the zdls5[mec-4::GFP+lin-15(+)] I. reporter line that ex-
presses GFP under the control of the neuron-specific mec-
4 promoter (33). To assess neuronal functionality we per-
formed an age-dependent longitudinal study, testing the
sensitivity of the animals to gentle touch triggered by
strokes with an eyelash hair to stimulate posterior or an-
terior neurons, respectively. Compared to the wt animals,
csb-1 mutants showed an accelerated age-dependent loss
of touch sensitivity. UV treatment exacerbated the age-
dependent touch insensitivity indicating that DNA damage
can promote the loss of neuronal functionality (Figure 2A,
statistics in Supplementary Table S2A, B).
In order to examine why the sensitivity to gentle
mechanosensory stimuli was lower in the csb-1 mutant
strain, we questioned whether the animals were losing
neuronal integrity. Using the double mutant zdls5[mec-
4::GFP+lin-15(+)]I;csb-1(ok2335), we scored for neu-
ronal defects that previously have been characterised in an
age-dependent analysis of neuronal decline (20). We iden-
tified a range of abnormalities, including axonal beading,
axonal degeneration, axonal disorganization (zig-zag-like
structures), axonal branching, protrusions emerging from
the neuronal cell body, and bridging of axons (Supple-
mentary Figure S2A). Axonal beading was the most abun-
dant structural aberration in wt and csb-1 mutants, which
prompted us to quantify this phenotype. We hypothesized
that the axonal beading was preceding the axonal degener-
ation. To examine this, we carried out a time-lapse study,
and confirmed that, over the course of several hours, an
axon with beads can increase in severity concomitantly with
a thinning of the axon, until it leads to breakages in the
axon, i.e. neurodegeneration (Figure 2B). We then counted
the number of beads in ALM and PLM neurons and cat-
egorized the animals into absent, mild, strong, severe and
extreme. Consistent with the functional degeneration ob-
served in Figure 2A, the csb-1 mutant strain showed a
stronger beading phenotype compared to wt animals, which
was enhanced upon UV irradiation (Figure 2C, statistics in
Supplementary Table S3A, B). Further, we quantified ax-
onal degeneration indicated by the absence of axons be-
tween beads in PLM neurons and found a significant in-
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Figure 2. Loss of neuronal integrity is accentuated in csb-1 mutants. (A) Gentle touch response assayed in the anterior part of the animal (ALM neurons),
or the posterior (PLM neurons), respectively. Animals were treated with UVB at young adult stage, and measured on the Day of UV radiation (Day 1), and
on the Days 3, 5, 8 and 11 thereafter. Plot shows nonlinear regression (curve fit) line. (B) Representative images of neuronal beading in a time-dependent
manner in animals expressing pmec-4GFP. Gentle touch mechanosensory neurons were irradiated at Day 1 of adulthood and neuronal beading was observed
for morphological changes at Day 8 (time: 0) after treatment. The first timepoint shows a neuron with beading. With time, the beading becomes more severe,
until it reaches a stage with breakages along the axon resulting in degeneration, which is indicated by white arrows. Scale bars are 25 m. (C) Quantification
of degeneration in anterior (ALM) and posterior (PLM) mechanosensory neurons. Animals were treated at young adult stage, and measured on the Day of
treatment (Day 1) and 7 Days after (Day 8). Degeneration is measured by quantifying the severity of beading per animal. Statistical analysis is available in
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Similar to UV irradiation, treatment with Illudin M signifi-
cantly enhanced the neuronal beading phenotype in the wt
background, and, even more severely, in CSB-1 deficient an-
imals (Figure 2D).
Loss of csb-1 causes an accumulation of dysfunctional mito-
chondria
CS patients display a variety of symptoms that can
also be found in mitochondrial diseases and the neu-
rological defects in CS might be connected to mito-
chondrial dysfunction (1,34). In human cell lines, CSB-
deficiency causes the accumulation of damaged mito-
chondria paralleled by altered mitochondrial function (6).
We employed the strains zcls14[myo-3::GFP(mit)] and
zcls17[ges-1::GFP(mit)] that express GFP with a mito-
chondrial targeting sequence under the control of a mus-
cle or intestine specific promoter, respectively, to visualize
mitochondrial content in C. elegans tissues (35). We found
that mitochondrial GFP levels in csb-1 mutants were sig-
nificantly higher as compared to wt worms, indicating an
increase in mitochondrial mass (Figure 3). However, ex-
posure to UV (25 and 50 mJ/cm2) caused an increase of
mitochondria-targeted GFP in wt animals, while csb-1 mu-
tants showed significantly less mitochondrial mass at 50
mJ/cm2 UVB (Figure 3A-C). We validated these results
for the zcls17[ges-1::GFP(mit)] strain by applying large-
particle flow cytometry for quantitative GFP measurements
in whole worms (Supplementary Figure S3A). An age-
dependent analysis revealed that mitochondrial GFP levels
were significantly elevated in csb-1 mutants at Day 1 and
Day 3 in adulthood compared to the wt, while at Day 5
the situation reversed for the intestinal mito::GFP reporter
(Figure 3D–F).
The higher levels of mitochondrial content in both tissue-
specific mitochondrial GFP transgenic lines in the csb-1
mutant strain suggest that the turnover of mitochondria
might be compromised, indicative of the accumulation of
damaged mitochondria. To address this question, we tested
the levels of active mitochondria via staining with tetram-
ethylrhodamine ethyl ester (TMRE), a positively charged,
cell permeant dye, which accumulates in functional mito-
chondria due to their negative membrane potential. Despite
their higher mitochondrial content, csb-1 mutants at Day 1
of adulthood showed similar levels of mitochondrial activ-
ity (Figure 4A-D, control). However, after treatment with
UV, the csb-1 mutants showed a significantly lower level of
active mitochondria, which was rescued by re-expression of
wt CSB-1 in the CSB-1::GFP rescue line (Figure 4A, C).
An analysis at different time-points during adulthood re-
vealed that csb-1 mutants contain less active mitochondria
at Day 3 and Day 5 of adulthood (Figure 4B, D). We further
validated the TMRE quantification of intact mitochondrial
levels after UVB irradiation by large-particle flow cytome-
try (Supplementary Figure S3B).
Mitochondrial dysfunction has been postulated as an im-
portant pathomechanism of CS (6,34). Therefore, we exam-
ined oxygen consumption rates (OCR) as a parameter for
respiratory chain activity. Under unperturbed conditions,
csb-1 mutants showed similar OCR as wt animals. When
irradiated at the L4 stage, wt and csb-1 mutant animals
displayed a dose-dependent reduction in the oxygen con-
sumption after 4 h. While wt animals recovered within 24 h,
the OCR dramatically decreased in csb-1 mutants upon 50
mJ/cm2 of UVB and failed to recover. Upon 25 mJ/cm2 we
observed a slight transient increase by 24 h in csb-1 mutants
pointing to a compensatory OCR increase (Figure 4E).
As CSB-1-mediated TC-NER is specifically required in
somatic tissues but not the germline where GG-NER pre-
dominates (14,15), we wished to decouple any potential
contribution by mitochondria in the germline to the OCR
measurements. To verify that such differences reflected
OCR in somatic tissues and were not due to effects of UV
on the germline we employed glp-1;csb-1 double mutants.
The GLP-1 protein is part of the Notch family of trans-
membrane receptor proteins and is involved in the regula-
tion of mitotic germ cell divisions. The glp-1(e2141) loss-
of-function allele is a temperature sensitive mutant, which
does not develop a germline when grown at 25◦C (36). We
hypothesized that the strains in the glp-1 background would
have a generally lower OCR due to the absence of an energy-
demanding organ such as the germline. Indeed, glp-1 mu-
tants showed a lower level of OCR compared to the wt,
and the glp-1;csb-1 double mutant displayed a lower level
of OCR compared to glp-1 or csb-1 single mutants, respec-
tively, while maintaining the accentuated reduction in re-
sponse to 50 mJ/cm2 in the csb-1 mutant strain (Figure 4F).
Taken together, these results suggest that the increased
mitochondrial mass in csb-1 mutants compensates for their
relative dysfunctionality, thus maintaining respiratory ac-
tivity. Only at a higher DNA damage load (50 mJ/cm2) res-
piratory activity cannot be maintained.
Csb-1 mutants show a hyperfused mitochondrial network
The observed accumulation of dysfunctional mitochon-
dria prompted us to further investigate the mitochondrial
network structure. CSB-deficient human cell lines display
a higher variation in mitochondrial width, indicative of
greater mitochondrial heterogeneity (6). Mitochondrial dy-
namics play a role in this diversity with fission and fusion as
key modulators of the organelle structure, which can be ac-
tivated or inhibited by different stressors. While mild stress
often leads to hyperfusion of mitochondria as a first line of
defence, a more severe stress leads to hyperfragmentation
and mitophagy in order to segregate and eliminate dysfunc-
tional mitochondria from the network (37). Indeed, when
treating the wt and csb-1 mutants with UV radiation, differ-
ent types of mitochondrial structure were observed, which
we categorized into tubular, intermediate, fused, hyper-
fused, fragmented, hyperfragmented, and degrading (Fig-
ure 5A). These classifications were used to score the phe-
notypes of the mitochondrial network structure in wt and
csb-1 mutant worms. In wt animals about 30% of the cells
had mitochondria that displayed tubular and intermediate
shapes. Upon UV exposure, these categories were severely
diminished (Figure 5B, left-side, statistics in Supplementary
Table S4). The majority of csb-1 mutants contained fused
or hyperfused mitochondria, while tubular or intermedi-
ate organelles were absent. Once stressed with UV, most
of the animals showed degrading or fragmented mitochon-
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Figure 3. Mitochondrial mass accumulates in csb-1 mutants. (A) Representative images of animals expressing muscular (pmyo-3mito::GFP, upper panel) or
intestinal (pges-1mito::GFP, lower panel) mitochondrial localized GFP upon UVB irradiation. The brightfield images and the corresponding fluorescence
images are shown. (B) Quantification of pmyo-3mito::GFP. (C) Quantification of pges-1mito::GFP. (n = 25 animals). Whiskers in (B) and (C) show the SD.
(n = 25 animals). Statistics were computed with the non-parametric Mann–Whitney test with *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001
and Tukey outliers are shown. (D) Representative images of animals expressing muscular (pmyo-3mito::GFP, upper panel) or intestinal (pges-1mito::GFP,
lower panel) GFP in mitochondria during adult ageing. The brightfield images and the corresponding fluorescence images are shown. (E) Quantification
of pmyo-3mito::GFP. (F) Quantification of pges-1mito::GFP. Error bars in (E) and (F) show the SD (n = 25 animals). Statistics were computed with the
non-parametric Mann–Whitney test with *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 and Tukey outliers are shown. Size bars in (A) and
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Figure 4. Csb-1 mutants display mitochondrial damage upon UVB and during ageing. (A) Representative images of animals stained with the mitochon-
drial dye TMRE upon UVB irradiation or (B) during ageing. Images show the brightfield and the corresponding red fluorescence signal of TMRE. (C)
Quantification of data represented in (A) comparing wt, csb-1(ok2335) and the CSB-1::GFP rescue (n = 25). (D) Quantification of data represented in
(B) (n = 25). (E) Oxygen consumption rates of csb-1 mutants 4, 24 and 48 h after UVB irradiation (n > 50 per group, >5 wells with biological replicates,
measured 10 times). Results are presented per wells containing 10 animals each. (F) Oxygen consumption rate of glp-1;csb-1 double-mutants after UVB
irradiation (n > 50 per group, >5 wells with biological replicates, measured 10 times). Panels (C) to (F) show boxplot whiskers representing the SD with
Tukey outliers indicated as dots. Statistical significance without specific indication always refers to the colour-matched untreated control. Statistics were
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Figure 5. Mitochondrial structure aberrations in csb-1 mutants. (A) Representative confocal images of the different mitochondrial morphology classes:
‘Tubular’ and ‘Intermediate’ mitochondrial classifications describe the unstressed mitochondrial status. The classifications ‘Fused’ and ‘Hyperfused’ belong
to the mechanism mitochondria undergo in order to recover from a mild stress. The classifications ‘Fragmented’, ‘Hyperfragmented’ and ‘Degrading’ belong
to the path mitochondria follow in response to acute stress. The dotted line represents the outline of the cell. Scale bars are 15 m. (B) Quantification of
mitochondrial classes in wt and the csb-1 mutant. Animals were treated at L4 stage, and measured 24 h after.
data suggest that endogenous DNA lesions that remain un-
repaired due to the csb-1 mutation result in mitochondrial
damage, which is greatly aggravated by exogenous DNA
damage conferred by UV irradiation.
Taken together, csb-1 mutant worms display multiple mi-
tochondrial defects and compromised respiratory activity,
concomitant with neuronal degeneration. Consistent with
such abnormalities resulting from the defects in repairing
endogenous DNA damage, both mitochondrial defects and
neurodegenerative phenotypes are greatly accentuated by
UV irradiation.
DISCUSSION
Here, we establish phenotypic parallels between human CS
and C. elegans carrying a csb-1 mutation that allows inves-
tigating the underlying role of DNA damage in accelerating
neuronal degeneration in vivo. We find that C. elegans csb-1
mutants display a range of phenotypes that reconstitute hu-
man CS pathologies (summarized in Table 1). We demon-
strate that csb-1 mutants show decreased tissue function-
ality as assayed by the highly sensitive assessment of pha-
ryngeal pumping activity. Similarly, human patients present
reduced tissue functionality and feeding (3,38–40). In con-
trast, Csb mutant mice show increased food consumption
and no apparent changes in overall tissue functionality
(6). We determine that csb-1 mutant worms have defects
in chemotaxis, sinusoidal locomotion and touch sensitiv-
ity pointing to a loss of neuronal functionality. These find-
ings are reminiscent of CS symptoms in human patients
who suffer from ataxia, spasticity and a demyelinating neu-
ropathy, resulting in impaired ambulation and reflexes, as
well as delayed motor and cognitive development (1,39).
In relation to the functional neurological decline, we vi-
sualised progressive neurodegeneration of mechanosensory
neurons, which play a multimodal role in touch sensation
and locomotion control of C. elegans (41). Although sub-
stantially varying across cases, brain atrophy, neuronal loss
and axonal degeneration commonly occur in CS patients
(42). Contrariwise, Csb mutant mice are lacking concrete
evidence for neuronal defects or neurodegeneration (7,43),
except for a loss of spiral gangliocytes in the inner ear of
old Csb mutant mice (6). Because of the limited pheno-
typic consequences of a Csb mutation in mice (see Table
1), the effect of the CSB deficiency on neuronal function-
ality has not been systematically studied in vivo. There-
fore, we characterized csb-1 mutant C. elegans as CS model
for studying morphological and molecular changes in neu-
rons and their phenotypic consequences on the animals’ be-
haviour. Consistent with the requirement of CSB to remove
UV-induced lesions in actively transcribed genes in cul-
tured, terminally differentiated human neurons (44), we ob-
served that neuronal defects and behavioural decline were
enhanced upon UV irradiation in wt animals and, more
severely, in csb-1 mutant worms. Similarly to UV irradia-
tion, treatment with Illudin M, which induces transcription-
blocking lesions (30), accelerates the functional decline and
neurodegeneration in csb-1 mutants. These results pinpoint
the causal effect of DNA lesions that obstruct transcription
elongation in triggering neurodegeneration. It will be highly
interesting to further evaluate the causal contribution of
transcription-blocking lesions in neurodegenerative disor-
ders occurring during normal ageing in humans. To this end
the nematode might serve as instructive in vivo model of
neurodegeneration because in contrast to in vitro studies in
neuronal cultures, the C. elegans CS model allows the inves-
tigation of the nervous system in a whole-organism context
during development and throughout the course of ageing.
Given that CS is a progeroid disease, insights into the






/nar/article/48/19/10973/5918321 by guest on 19 N
ovem
ber 2020
Nucleic Acids Research, 2020, Vol. 48, No. 19 10983
Table 1. Comparison of characteristics of CSB-deficient models. N/A refers to phenotypes that have not been yet investigated
Feature Description Human Mus musculus C. elegans
UV sensitivity Development X X X
Post-mitotic X X X
Neuronal Degeneration X (X) X
Functional deficit X - X
Mitochondria Dysfunction X X X
Structure N/A X X
Healthspan Tissue functionality X - X
Fertility Viable offspring - X X
Feeding Difficulty X - X
Cancer Absence X X N/A
Muscle functionality Decreased X - X
Development Delay X - X*
Body size Reduction X - X*
*This feature in worms has been observed only upon UV irradiation.
standing of the ageing process. In the C. elegans CS model,
we show a progressive, age-dependent decline in pharyn-
geal pumping and mechanosensation paired with a gradual
loss of neuronal integrity. Despite these functional defects,
csb-1 mutant worms have a normal lifespan that is reduced
upon UV-induced DNA damage (13,45). The progressive
loss of neuronal integrity in csb-1 mutants was character-
ized by an early-onset of increased beading that precedes ax-
onal degeneration. We also detected aberrant neurite mor-
phology, bubble-like lesions (bridging) and neurite sprout-
ing (branching) along the axons of mechanosensory neu-
rons; features that naturally appear during advanced age
in the C. elegans neuronal system (20). Neuronal mainte-
nance in ageing is governed by the Jun kinase (JNK-1) and
insulin signalling via DAF-16/FOXO (20,46,47), both of
which have been implicated in the DNA damage response
(DDR; (15,48). We previously showed that the activation of
the transcription factor DAF-16 upon UV-induced DNA
damage promotes developmental growth and lifespan in
csb-1 mutants thus counteracting the consequences of un-
repaired DNA damage (13,15). Curiously, age-dependent
defects in posterior touch neurons (PLM) are significantly
more severe as compared to the anterior (ALM), which
might rear from the ability of touch response neurons to
differentially adapt to environmental signals that modu-
late sensory output: While ALMs are capable to respond
to insulin-peptides that converge on AKT kinases (AKT-
1) and DAF-16/FOXO to mount a stress-induced sensory-
adaptation, PLMs are known to lack this level of modula-
tion (49,50). Similarly, the DDR could be differentially reg-
ulated in specific neuronal subsets.
What homeostatic processes might be perturbed in csb-
1 mutants that could impact neuronal integrity? Following
this intriguing question, we have characterized alterations
in mitochondrial morphology in our CS model. Mitochon-
drial decline is a hallmark of ageing, and mitochondrial
homeostasis is essential for neuronal maintenance (51,52).
Cells of Csb deficient mice accumulate damaged mitochon-
dria, which might be explained by a defect of mitochondrial
clearance via autophagy (34). We demonstrate that the lack
of the CSB-1 protein leads to the accumulation of mito-
chondria in muscles and the intestine, while mitochondrial
activity throughout tissues in the animal is reduced. Our
data suggest that these events are unfolding organism-wide
rather than tissue-specific. Further, we detect expansion of
the mitochondrial mass and a hyperfused mitochondrial
network, while respiratory activity is largely maintained.
Our results on mitochondrial morphology changes are con-
sistent with previous findings in C. elegans mutants for
the csa-1 or csb-1 genes (53). Upon exogenous DNA dam-
age, however, the mitochondria fragment and csb-1 mutants
show a strong dampening of oxygen consumption indicative
of mitochondrial dysfunction. These observations suggest
that mitochondria compensate for the defect in repairing
endogenous DNA lesions in csb-1 mutants by expansion of
the network to maintain respiratory activity. However, this
adaptive response might be overwhelmed when exogenous
lesions cannot be repaired. It will be highly interesting to
better understand the molecular mechanisms of the com-
pensatory mitochondrial stress response and determine its
role in maintaining tissue functionality, and more specifi-
cally neuronal integrity, amid CS pathologies.
The CS model we establish here for neuronal degenera-
tion and mitochondrial aberrations in C. elegans csb-1 mu-
tants could fill an important experimental gap between the
complex human CS pathologies and the lack of experimen-
tally traceable metazoan in vivo models reflecting the pheno-
typic disease manifestations. The completely mapped neu-
ral circuitry of C. elegans will aid in characterising the spe-
cific neurons or type of neurons that are affected by de-
generation in csb-1 mutants and by DNA damage. This
model might also shed light onto the long-standing ques-
tion why neurons are particularly sensitive to DNA repair
defects, given that not only CS but a large number of con-
genital DNA repair deficiencies are characterized by neu-
rodegeneration (54). Our results indicate that transcription-
blocking lesion might have a profound effect on trigger-
ing neurodegeneration. It is conceivable that the typically
high transcription rates of neurons could make them par-
ticularly vulnerable to lesions induced by endogenous geno-
toxins that result from the high neuronal metabolic activ-
ity. The CS nematode model can readily be exploited not
only for mechanistic, physiological and genetic studies but
also for identifying and characterizing pharmacological in-
terventions that might ameliorate the disbalance of the mi-
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C. elegans CS model might thus yield important new in-
sight into the causal role of DNA damage in the age-related
progressive loss of neuronal integrity and provide an exper-
imental model for neurodegenerative diseases.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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